• Users Online: 270
  • Print this page
  • Email this page

  Reader Comments

Year : 2019 | Volume:  2 | Issue Number:  4

ORIGINAL ARTICLE

Phase 2 clinical trial of VAL-083 as first-line treatment in newly-diagnosed MGMT-unmethylated glioblastoma multiforme (GBM): Halfway report

Guo Chengcheng, Yang Qunying, Li Jiawei, Wu Shaoxiong, Deng Meiling, Du Xiaojing, Sai Ke, Jiang Xiaobing, Chen Zhenghe, Zhang Ji, Lin Fuhua, Wang Jian, Chen Yinsheng, Ke Chao, Zhang Xiangheng, Ju Xue, Mou Yonggao, Bacha Jeffrey, Steino Anne, Kanekal Sarath, Kwan Claire, Johnson Gregory, Schwartz Richard, Langlands John, Brown Dennis, Chen Zhong-ping

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks


 

Back To Article